Moore Capital Management LP Acquires Shares of 29,635 Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Moore Capital Management LP purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 29,635 shares of the company's stock, valued at approximately $1,175,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Integral Health Asset Management LLC acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $11,895,000. Irenic Capital Management LP acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $5,309,000. J. Goldman & Co LP acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $25,057,000. Gotham Asset Management LLC acquired a new stake in Acadia Healthcare in the 4th quarter valued at approximately $6,243,000. Finally, Granahan Investment Management LLC increased its holdings in Acadia Healthcare by 190.9% in the 4th quarter. Granahan Investment Management LLC now owns 142,236 shares of the company's stock valued at $5,640,000 after purchasing an additional 93,346 shares during the last quarter.

Acadia Healthcare Stock Up 2.0%

Shares of Acadia Healthcare stock traded up $0.51 during trading on Friday, hitting $26.15. 2,120,582 shares of the stock were exchanged, compared to its average volume of 1,703,613. Acadia Healthcare Company, Inc. has a 12-month low of $20.36 and a 12-month high of $82.41. The stock has a market cap of $2.41 billion, a price-to-earnings ratio of 8.57, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm's 50-day moving average price is $26.25 and its 200 day moving average price is $35.83.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same period in the previous year, the company earned $0.84 earnings per share. Acadia Healthcare's quarterly revenue was up .3% compared to the same quarter last year. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have commented on ACHC. Barclays dropped their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research note on Wednesday. Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. KeyCorp dropped their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday. Guggenheim began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Finally, Bank of America dropped their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.